For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News

✖
 ENGLISH
 ENGLISH  THAI
BREAKING NEWS
Source: COVID-19 Alarms!  Oct 24, 2021  3 years, 4 weeks, 4 hours, 41 minutes ago

UK Health Security Document Indicates That That N Antibody Levels Appear To Be Lower In Fully Vaccinated Individuals Who Acquire Infection!

News Coronavirus Vaccine News
UK Health Security Document Indicates That That N Antibody Levels Appear To Be Lower In Fully Vaccinated Individuals Who Acquire Infection!
Source: COVID-19 Alarms!  Oct 24, 2021  3 years, 4 weeks, 4 hours, 41 minutes ago
(Note: Before reading this article, with winter fast approaching, and more Delta sub-variants emerging along with other new variants and recombinant strains, we strongly advised that everyone gets vaccinated fast especially since a majority are ignorant and do not have access to other protocols that can ward off these emerging variants.(We are not talking about Ivermectin which does not work on the emerging variants and strains and neither are we going to be divulging these new protocols for free unlike the stupidity of doing so in the past with the initial wild-type strains!) We cannot comment about what level of the protection that the vaccines will ultimately offer but look at things this way…sooner or later a majority of you are going to end up dead..either by contracting the virus, by long-COVID, by constant reinfections with newer emerging variants, sub-variants or recombinant strains or simply by stress! The surges are not going away anytime soon! At least buy some time and maybe take a gamble!....ok..now that we have done with the obligatory rituals to appease the social media platforms and also search engines, lets continue…)

 
A document by the British health authorities reveals that recent observations from UK Health Security Agency (UKHSA) surveillance data indicates that N antibody levels appear to be lower in individuals who acquire infection following 2 doses of vaccination.
 
That single line that has lots of implications is found in the second last line of the third paragraph on page 23 of the document. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027511/Vaccine-surveillance-report-week-42.pdf
 
We have been bombarded with so call counter reports claiming that those vaccinated have a better immune response than that of natural immunity despite more than 91 published studies showing otherwise! (Please refer to list at the end of the article), so a question arises, are we on the right track to simply have antibodies that are only generated by the vaccines that target the S-proteins of the SARS-CoV-2 only.
 
Many of the new variants are also having mutations taking place on the N proteins and some of these mutations have been influencing immune evasiveness and even transmissibility directly or indirectly.
 
To date we know that these vaccines do not stop infection or transmission of the virus but according to ‘experts’, they stop disease progression, prevent hospitalization and also prevents deaths.
 
However, in the most vaccinated countries like Singapore, United Kingdom and Israel, we are also seeing fully vaccinated people who had their vaccines not more than even six months, now being hospitalized, being admitted to ICUs due to disease severity and some also dying.
 
There are reports now that the effectiveness of the vaccines wanes after six months and that booster doses are being required.
 
What this statement in the British health document could be implying is that they are now finding the vaccine interferes with the human body’s innate ability after infection to produce antibodies against not just the spike protein but other pieces of the virus. Specifically, vaccinated people don’t seem to be producing antibodies to the nucleo capsid protein, the shell of the virus, which are a crucial part of the response in unvaccinated people. (That’s what we have been told by the experts!)

Perhaps the experts out there could give us more insights as to why we should not be worrying about this.
 
Now I am not going to write more….for those of you with any brains, we have more than enough studies and past articles covered in Thailand Medical News for you to come up with you own inferences or better still, just wait for a few more surges!
 
But before any stupid idiots come up with any stupid conspiracy theories. Let me assure you..SARS-CoV-2 is real, COVID-19 is real…long COVID-19 is real but what is not being told to you is that …there are hundreds of variants, sub-variants and recombinant strains with worrying mutations on them  out there that have already emerged but are still fighting for viral fitness and need to evolve to become predominant in circulation. Its only a matter of time!
 
Below is a list of the 91 studies talking about natural immunity.
 
1)Necessity of COVID-19 vaccination in previously infected individuals, Shrestha, 2021
2) SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls, Le Bert, 2020
3) Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections,Gazit, 2021
4) Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection, Le Bert, 2021
5) Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection, Israel, 2021
6) SARS-CoV-2 re-infection risk in Austria, Pilz, 2021
7) mRNA vaccine-induced SARS-CoV-2-specific T cells recognize B.1.1.7 and B.1.351 variants but differ in longevity and homing properties depending on prior infection status, Neidleman, 2021
8) Good news: Mild COVID-19 induces lasting antibody protection, Bhandari, 2021
9) Robust neutralizing antibodies to SARS-CoV-2 infection persist for months, Wajnberg, 2021
10) Evolution of Antibody Immunity to SARS-CoV-2, Gaebler, 2020
11) Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans, Haveri, 2021
12) Quantifying the risk of SARS‐CoV‐2 reinfection over time, Murchu, 2021
13) Natural immunity to covid is powerful. Policymakers seem afraid to say so, Makary, 2021
14) SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity, Nielsen, 2021
15) Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel, Goldberg, 2021
16) Incidence of Severe Acute Respiratory Syndrome Coronavirus-2 infection among previously infected or vaccinated employees, Kojima, 2021
17) Having SARS-CoV-2 once confers much greater immunity than a vaccine—but vaccination remains vital, Wadman, 2021
18) One-year sustained cellular and humoral immunities of COVID-19 convalescents, Zhang, 2021
19) Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19, Rodda, 2021
20) Discrete Immune Response Signature to SARS-CoV-2 mRNA Vaccination Versus Infection, Ivanova, 2021
21) SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans, Turner, 2021
22) SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN), Jane Hall, 2021
23) Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers, Houlihan, 2020
24) Antibodies to SARS-CoV-2 are associated with protection against reinfection, Lumley, 2021
25) Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells, Cohen, 2021
26) Single cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine, Sureshchandra, 2021
27) SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy, Abu-Raddad, 2021
28) Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity, Ripperger, 2020
29) Anti-spike antibody response to natural SARS-CoV-2 infection in the general population, Wei, 2021
30) Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers, Lumley, 2021
31) Researchers find long-lived immunity to 1918 pandemic virus, CIDRAP, 2008
and the actual 2008 NATURE journal publication by Yu
32) Live virus neutralisation testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2, Gonzalez, 2021
33) Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals, Camara, 2021
34) Op-Ed: Quit Ignoring Natural COVID Immunity, Klausner, 2021
35) Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection, Harvey, 2021
36) SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study, Letizia, 2021
37) Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar, Bertollini, 2021
38) Natural immunity against COVID-19 significantly reduces the risk of reinfection: findings from a cohort of sero-survey participants, Mishra, 2021
39) Lasting immunity found after recovery from COVID-19, NIH, 2021
40) SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study From the Faroe Islands, Petersen, 2021
41) SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells, Jung, 2021
42) Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection, Ansari, 2021
43) COVID-19 natural immunity, WHO, 2021
44) Antibody Evolution after SARS-CoV-2 mRNA Vaccination, Cho, 2021
45) Humoral Immune Response to SARS-CoV-2 in Iceland, Gudbjartsson, 2020
46)  Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection, Dan, 2021
47) The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis of 12 011 447 individuals, Chivese, 2021
48) Reinfection Rates among Patients who Previously Tested Positive for COVID-19: a Retrospective Cohort Study, Sheehan, 2021
49) Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy, Vitale, 2020
50) Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection, Hanrath, 2021
51) mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status, Neidleman, 2021
52) Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals, Grifoni, 2020
53) NIH Director’s Blog: Immune T Cells May Offer Lasting Protection Against COVID-19, Collins, 2021
54) Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants, Wang, 2021
55) Why COVID-19 Vaccines Should Not Be Required for All Americans, Makary, 2021
56) Protracted yet coordinated differentiation of long-lived SARS-CoV-2-specific CD8+ T cells during COVID-19 convalescence, Ma, 2021
57) Decrease in Measles Virus-Specific CD4 T Cell Memory in Vaccinated Subjects, Naniche, 2004
58) Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination, Palm, 2019
59) SARS-CoV-2 specific memory B-cells from individuals with diverse disease severities recognize SARS-CoV-2 variants of concern, Lyski, 2021
60) Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection, Wang, 2021
61) CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants, Redd, 2021and Lee, 2021
62) Exposure to common cold coronaviruses can teach the immune system to recognize SARS-CoV-2,La Jolla, Crotty and Sette, 2020
63) Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans, Mateus, 2020
64) Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection, Dehgani-Mobaraki, 2021
65) Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19, Juno, 2020
66) Convergent antibody responses to SARS-CoV-2 in convalescent individuals, Robbiani, 2020
67) Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence, Hartley, 2020 
68) Had COVID? You’ll probably make antibodies for a lifetime, Callaway, 2021
69) A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2, Majdoubi, 2021
70) SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19, Braun, 2020
71) Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection, Wang, 2021
72) One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms, Rank, 2021
73) IDSA, 2021
74) Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study, Holm Hansen, 2021
75) Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity, Moderbacher, 2020 
76) Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals, Ni, 2020
77) Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection, Zuo, 2020
78) Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees, Tarke, 2021
79) A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report, Perez, 2021
80) Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients, Iyer, 2020
81) A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States, Alfego, 2021
82) What are the roles of antibodies versus a durable, high- quality T-cell response in protective immunity against SARS-CoV-2? Hellerstein, 2020
83) Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients, Peng, 2020
84) Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19, Sekine, 2020
85) Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients, Lafron, 2021
86) SARS-CoV-2 T-cell epitopes define heterologous and COVID-19 induced T-cell recognition, Nelde, 2020
87) Karl Friston: up to 80% not even susceptible to Covid-19, Sayers, 2020
88) CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses, Lineburg, 2021
89) SARS-CoV-2 genome-wide mapping of CD8 T cell recognition reveals strong immunodominance and substantial CD8 T cell activation in COVID-19 patients, Saini, 2020
90) Equivalency of Protection from Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis, Shenai, 2021
91) ChAdOx1nCoV-19 effectiveness during an unprecedented surge in SARS CoV-2 infections, Satwik, 2021
 
 
 
 
 

MOST READ

Nov 08, 2024  13 days ago
Nikhil Prasad
COVID-19 and the Hidden Threat of Cytomegalovirus (CMV) Reactivation
Nov 05, 2024  17 days ago
Nikhil Prasad
Study Reveals That COVID-19 Alters Key Human Genes
Oct 07, 2024  2 months ago
Nikhil Prasad
Study reveals the SARS-CoV-2 spike protein interacts with over 60,000 host proteins and may trigger carcinogenesis!
Aug 08, 2024  4 months ago
Nikhil Prasad
COVID-19 induced endothelial dysfunction will lead to a pandemic of chronic kidney and cardiovascular diseases
Aug 04, 2024  4 months ago
Nikhil Prasad
COVID-19's unexpected impact - Rising orofacial pain among infected individuals
Jul 25, 2024  4 months ago
Nikhil Prasad
Murine study shows how COVID-19 increases risk for stroke
Jul 24, 2024  4 months ago
Nikhil Prasad
COVID-19 can cause Osteomyelitis of the jaw
Jul 22, 2024  4 months ago
Nikhil Prasad
COVID-19 causes Blood DNA Methylation, a potential biomarker for Long COVID severity
Jul 22, 2024  4 months ago
Nikhil Prasad
Doctors from Turkey warns that children exposed to SARS-CoV-2 are at risk of acute kidney injury
Jul 08, 2024  5 months ago
Nikhil Prasad
Unknown To Many Including Doctors, COVID-19 Causes Parsonage Turner Syndrome
Jun 26, 2024  5 months ago
Nikhil Prasad
BREAKING! Mild COVID Causes A Slow Progressing Eye Debilitating Condition That Most Are Not Even Aware Of Till It's Too Late!
Jun 24, 2024  5 months ago
Nikhil Prasad
COVID-19's Hidden Impact on Eyes: Unveiling Rare Retinal Conditions
Jun 23, 2024  5 months ago
Nikhil Prasad
Somnolence And Shingles Seems To Be New Symptom/Manifestation Of COVID-19 KP.3 And LB.1 Infections!
Jun 22, 2024  5 months ago
Nikhil Prasad
Herbs And Phytochemicals: Fermented Codonopsis lanceolata Root Extract Shows Promise Against Influenza A Virus
Jun 12, 2024  5 months ago
Nikhil Prasad
Most Long COVID Patients Likely To Develop New Onset Psychiatric Disease!
Mar 12, 2024  8 months ago
Nikhil Prasad
Mild Or Moderate COVID-19 Causes Accelerated Brain Aging Especially In Young To Early Middle-Aged Adults!
Mar 10, 2024  9 months ago
Nikhil Prasad
Six Percent Of All Post-COVID Patients Who Have Hip Discomfort Likely To Have Developed Avascular Necrosis Of The Femoral Head!
Mar 05, 2024  9 months ago
Nikhil Prasad
Austrian Scientists Claim That High-Density Lipoproteins Can Be Used As Antivirals Against COVID-19 Infections
Feb 20, 2024  9 months ago
Nikhil Prasad
New Measles Variant That Can Evade Current Diagnostics Identified In Italy! More New Strains To Be Announced Soon!
Jan 02, 2024  11 months ago
Nikhil Prasad
BREAKING COVID-19 News! Study Claims That Omicron Infections Can Lead To Acute Primary Angle Closure And Also Primary Angle Closure Glaucoma!
Dec 16, 2023  11 months ago
Nikhil Prasad
BREAKING COVID-19 News! Australian Scientists Discover A microRNA Called CoV2-miR-O8 That Is Encoded By SARS-CoV-2 And Is Possibly Pathogenetic!
Dec 15, 2023  11 months ago
Nikhil Prasad
COVID-19 News: Foods Rich In XeSiAs-Neu5Gc Contributes To Xenosialylation That Causes Worse Outcomes In SARS-CoV-2 Infections And Vaccination!
Oct 23, 2023  1 year ago
Nikhil Prasad
COVID-19 News: SARS-CoV-2 Is Likely An Oncogenic Virus That Will Cause Lung, Colorectal, Oral, Pancreatic And Breast Cancers In The Long Term!
Jun 29, 2023  1 year ago
Medical News - SARS-CoV-2 - IGF2BP1
BREAKING! Scientists Warns That SARS-CoV-2 Also Interacts With IGF2BP1- An Oncofetal RNA-Binding Protein That Typically Fuels Tumor Virus Propagation!
Jun 10, 2023  1 year ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
BREAKING NEWS! Even Asymptomatic SARS-CoV-2 Infections Cause DNA Methylation And Epigenetic Changes, Leading to Immune Dysregulation!
May 13, 2023  2 years ago
COVID-19 News - Viral Peristence - Long COVID
There Is No Such Thing As Long COVID! SARS-CoV-2 Exposure Causes Persistent Infections Along With Continuous Presence Of Short Viral RNAs (svRNAs)!
Feb 07, 2023  2 years ago
COVID-19 News - Breast Cancer
BREAKING! COVID-19 News: SARS-CoV-2 Infections Lead To Increased Risk Of Breast Cancer, Recurrence Of Breast Cancer And Also Breast Cancer Metastasis!
Nov 29, 2022  2 years ago
COVID-19 News - D-Alanine Supplements Prevents COVID-19 Severity
BREAKING COVID-19 News: Japanese Scientists Find That Supplementation With The Amino Acid D-Alanine Can Help Prevent And Treat COVID-19 Severity!
Sep 28, 2022  2 years ago
Source: Medical News - SARS-CoV-2 Reinfections - Omicron
Study Validates Previous Findings That SARS-CoV-2 Reinfections Are Now Occurring At Shorter Intervals. Current CDC and ECDC Reinfection Definitions Are Obsolete!
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
BREAKING! Study Finds That Cancer Causing Genes Are Upregulated In SARS-CoV-2 Infected Individuals!
Jun 27, 2022  2 years ago
Source: Medical News -SARS-CoV-2 Reduces Human Life Spans
BREAKING! Hypothesis That Majority Exposed To SARS-CoV-2 Will Have Shortened Lifespans Validated By Study Showing NSP2 Impairs Human 4EHP-GIGYF2 Complex!
Dec 25, 2021  3 years ago
Source: SARS-CoV-2 Viral Persistence
BREAKING! U.S. NIH Study Shockingly Reveals SARS-CoV-2 Viral Persistence Throughout Human Body And In The Brain Even In Those Who Were Asymptomatic!
Nov 18, 2021  3 years ago
Source: SARS-CoV-2-Cancer
BREAKING! New International Study Warns That SARS-CoV-2 Infections Will Lead To Cancers Especially Colorectal Cancers Due to Disruption In Autophagy!
Nov 13, 2020  4 years ago
Source: COVID-19 Genetics
BREAKING! COVID-19 Genetics: Yale Scientist Identify Eight ‘Super’ Genetic Variants In White People That Increases COVID-19 Death Risk!
Nov 05, 2020  4 years ago
Source: Ozone Water-COVID-19
Japanese Study Shows That Ozone Water Rapidly Inactivates SARS-Cov-2 Coronavirus, Making It An Ideal COVID-19 Disinfectant And Sanitizer
Sep 30, 2020  4 years ago
Source: BREAKING NEWS
BREAKING NEWS! COVID-19 Study Reveals That SARS-CoV-2 Uses CD4 Cells To Infect T-helper Lymphocytes. COVID-19 A Potent Version Of Airborne HIV?

FROM DENTAL NEWS

LATEST ON DOCTOR INTERVIEWS

World COVID-19 News
COVID-19 Diagnostics
COVID-19 Drugs
COVID-19 Supplements
COVID-19 Herbs
COVID-19 Disinfectants
COVID-19 Mutations
COVID-19 Research
COVID News
Long COVID
COVID-19 Vaccines
COVID-19 Clinical Care
Medical Press Releases
Medical Innovations & Startups
AI in Medicine
Thailand Biotech News
Medical Spheres Bulletins
Medical White Papers
Medical Packages
Medical Tips
Medical Support Groups
Medical Tourism
TNM Aristrocrat Club
Medical Journals
Thai Herbal Products
TMN Medical Mart
Wellness Centers
Rehab Centers
Medsiam App